Retour sur lavenir.net
   MELEXIS 65.250 € (+0,31 %)     UCB 221.300 € (-1,25 %)     TESSENDERLO 21.750 € (+4,57 %)     SOFINA 245.400 € (+0,25 %)     GBL 73.750 € (+0,27 %)     RETAIL ESTATES 66.000 € (-0,30 %)     AB INBEV 67.740 € (+0,44 %)     OXURION 0.003 € (+15,38 %)     PROXIMUS 6.290 € (-0,16 %)     AGFA-GEVAERT 0.450 € (+4,65 %)     ELIA GROUP 128.200 € (+0,94 %)     KBC 133.000 € (+0,08 %)     DEME GROUP 183.000 € (+7,52 %)     ONTEX GROUP 2.650 € (-0,38 %)     SYENSQO 80.450 € (+1,26 %)     CENERGY 22.880 € (+0,26 %)     CAMPINE 197.500 € (-0,25 %)     KBC ANCORA 94.100 € (-0,11 %)     D'IETEREN GROUP 177.900 € (+1,02 %)     EVS 29.950 € (0,00 %)     MONTEA 66.500 € (-0,30 %)     DECEUNINCK 2.415 € (+0,63 %)     COLRUYT 39.180 € (-0,20 %)     WDP 21.520 € (-0,09 %)     SOLVAY 25.640 € (+0,23 %)     AEDIFICA 69.000 € (-0,50 %)     RECTICEL 12.860 € (+0,78 %)     AGEAS 74.700 € (+0,61 %)     SHURGARD 23.550 € (-0,84 %)     NYRSTAR 0.060 € (0,00 %)     ECONOCOM GROUP 1.460 € (-1,02 %)     GIMV 44.300 € (+0,23 %)     ACKERMANS V.HAAREN 263.800 € (+2,41 %)     ARGENX SE 905.600 € (+3,00 %)     TUBIZE-FIN 190.400 € (-0,88 %)     KINEPOLIS GROUP 45.950 € (-0,76 %)     IMMO MOURY 32.200 € (0,00 %)     BIOTALYS 2.700 € (+0,93 %)     NYXOAH 1.468 € (+2,09 %)     BARCO 7.765 € (+0,52 %)     VAN DE VELDE 30.200 € (+1,34 %)     ONWARD MEDICAL 2.310 € (+0,65 %)     CARE PROPERTY INV. 12.100 € (-0,98 %)     WAREHOUSES ESTATES 38.200 € (0,00 %)     BPOST 1.304 € (+0,15 %)     AZELIS GROUP 12.130 € (+1,08 %)     EXMAR 11.700 € (+1,74 %)     UMICORE 23.280 € (-0,34 %)     FAGRON 22.550 € (+0,45 %)     TINC 11.220 € (0,00 %)     WERELDHAVE BELGIUM 51.600 € (-1,15 %)     BELYSSE GROUP 0.475 € (-5,00 %)     CMB.TECH 15.440 € (-0,13 %)     CIE BOIS SAUVAGE 298.000 € (+0,68 %)     EKOPAK 3.730 € (-0,13 %)     SIPEF 103.000 € (+1,78 %)     BEKAERT 38.100 € (+0,40 %)     ATENOR 1.310 € (+1,16 %)     XIOR 27.100 € (-0,37 %)     HOME INVEST BE. 19.100 € (-0,10 %)  
   FDJ UNITED 22.400 € (+0,13 %)     HAVAS 18.600 € (-0,53 %)     ATON 0.018 € (-8,08 %)     KLEPIERRE 38.840 € (-0,77 %)     AHOLD DEL 31.090 € (-0,32 %)     L'OREAL 390.100 € (+0,41 %)     ING GROEP N.V. 30.390 € (+0,76 %)     TOTALENERGIES 74.350 € (-1,78 %)     HERMES INTL 1 571.500 € (+0,96 %)     AIRBUS 207.000 € (+1,20 %)     SCHNEIDER ELECTRIC 298.700 € (+0,83 %)     AEGON 7.980 € (+0,86 %)     SOCIETE GENERALE 74.820 € (-0,27 %)     ASML HOLDING 1 496.800 € (-0,28 %)     MOTA ENGIL 4.702 € (+0,90 %)     KENDRION 19.920 € (+5,29 %)     HEINEKEN 72.700 € (+0,39 %)     VINCI 120.300 € (+0,59 %)     LVMH 453.650 € (+0,65 %)     RANDSTAD NV 39.965 € (+0,44 %)     SBM OFFSHORE 34.000 € (-1,33 %)     STMICROELECTRONICS 42.825 € (+0,63 %)     BE SEMICONDUCTOR 197.500 € (-0,85 %)     J.MARTINS,SGPS 18.180 € (-0,16 %)     SHELL PLC 38.970 € (-1,59 %)     VETOQUINOL 71.000 € (+0,57 %)     ASM INTERNATIONAL 824.600 € (-0,43 %)     LEGRAND 137.350 € (+0,62 %)     CORBION 19.920 € (+1,12 %)     METROPOLE TV 12.140 € (+0,17 %)     AVANTIUM 4.920 € (+0,82 %)     UNILEVER 55.880 € (+0,40 %)     KERING 251.800 € (+1,86 %)     ARCELORMITTAL SA 64.700 € (+3,42 %)     LAKEFRONT BIOTHER. 25.540 € (+0,39 %)     NFL BIOSCIENCES 0.882 € (-1,45 %)     SAFRAN 350.400 € (+1,92 %)     AXA 43.720 € (+0,09 %)     SANOFI 78.910 € (+0,22 %)     SOITEC 109.000 € (0,00 %)     RENAULT 26.980 € (-1,50 %)     LDC 109.000 € (-0,18 %)     ASR NEDERLAND 70.020 € (-1,07 %)     INNATE PHARMA 1.878 € (-0,11 %)     PUBLICIS GROUPE SA 103.100 € (-0,24 %)     PLANISWARE 23.900 € (-3,63 %)     ID LOGISTICS GROUP 336.000 € (-0,44 %)     CVC CAPITAL 14.950 € (-0,73 %)     ALSTOM 16.560 € (+2,35 %)     North Atlantic En. 76.150 € (-2,62 %)     CRCAM PARIS ET IDF 116.680 € (-0,36 %)     ACCOR 47.450 € (+1,69 %)     EMEIS 13.700 € (-0,72 %)     VALNEVA 2.867 € (-0,93 %)     EIFFAGE 118.650 € (0,00 %)     EXOR NV 72.000 € (+0,49 %)     BNP PARIBAS ACT.A 105.600 € (+1,11 %)     UBISOFT ENTERTAIN 5.376 € (-3,14 %)     CREDIT AGRICOLE 19.065 € (+0,32 %)     ABN AMRO BANK N.V. 41.240 € (+0,86 %)  
News Réglementées
26/08/2026 09:00

Original-Research: Emerald Horizon AG (von NuWays AG): BUY

Original-Research: Emerald Horizon AG - from NuWays AG

26.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Emerald Horizon AG

Company Name:Emerald Horizon AG
ISIN:AT0000A3UZE1
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 1,300
Target price on sight of:12 months
Last rating change:
Analyst:Jorge Gonzalez

Test Loop with VDL kicks off the next phase of ADES development

Emerald Horizon (SMRX) has announced the start of its ADES Test Loop programme together with industrial partner VDL Groep. According to the company, the Test Loop will represent the first integrated system test for ADES, bringing together components that have so far largely been developed and validated individually. The project is designed to validate the interaction of key fluid-thermodynamic components and systems, including the pump, molten-salt circulation, piping, heat exchanger, measurement and instrumentation, and control systems.

The Test Loop builds on several years of component-level development and testing across the ADES architecture. Emerald reports previous work covering neutron and proton generation, small-scale accelerator testing and nuclear measurement technology, alongside software-based simulation and digital-twin capabilities for nuclear physics and multiphysics modelling. The focus is therefore progressively shifting from individual components towards their interaction within an integrated system as ADES advances towards prototype development.

According to Emerald, four previous generations of the Loop have already been tested in hardware in Graz, with the upcoming Test Loop representing one of the final development steps before a further loop is developed for the ADES prototype targeted for 2029 (current Test Loop expected to run for c. 12–18 months; eNuW).

VDL partnership moves into project execution. Importantly, the Test Loop kick-off will include the signing of a project-specific agreement with VDL Groep under the long-term framework agreement signed by both companies in November 2025. While the framework covers the co-development and production of ADES and CALstore (thermal storage) technologies and components, each individual project requires a separate project agreement. The agreement will be signed alongside the official Test Loop kick-off at SMRX's main R&D laboratory in Graz on 8 September.

VDL will contribute its systems-engineering, manufacturing and supply-chain expertise to the Test Loop, incorporating the findings from its feasibility work into the final design. Importantly, the system is already being designed with subsequent industrial serial production and scalability in mind, supporting the development path towards the targeted ADES prototype.

In our view, the combination of the first integrated ADES system test and the transition of the VDL partnership into project-specific execution represents a key technical and industrialisation milestone for ADES, the main source of SMRX's long-term value potential. Successful execution should progressively reduce development and industrialisation risk on the path towards the targeted 2029 prototype and serial production from 2031 onwards.

We leave our estimates and € 1,300 PT unchanged. While the announcement does not warrant changes to our ADES deployment assumptions at this stage, successful execution would provide further support for the development roadmap underlying our valuation.

You can download the research here: emerald-horizon-ag-2026-08-26-update-en-16990
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2388700  26.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière